NUVB FY 2021 Earnings — Nuvation Bio Inc. Revenue & Financial Results | Market Cap Arena

NUVBNuvation Bio Inc.

$2B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$93M

Net Income

-$87M

EPS (Diluted)

$-0.44

Cash Flow

Operating Cash Flow

-$68M

Free Cash Flow

-$68M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$776M

Total Liabilities

$30M

Stockholders' Equity

$746M

Cash & Equivalents

$132M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$103,000	+100.0%
Operating Income	-$93M	-$44M	-114.3%
Net Income	-$87M	-$42M	-108.5%